Etymology: From Latin pulsare (to beat, to strike) + -ance (state or quality of). Mid-19th century term largely superseded by "angular velocity" in modern usage.
Most science organizations have the taste to know what to build. What they're missing is someone in the room who has done it before.
Innovators know the science cold but often lack the operator experience to turn it into product at scale. Builders can ship product at scale but don't always have the scientific fluency the life sciences market demands. Operators run technology at scale but don't always have the technical lens to tell which emerging tools are worth the bet. Funders know the field they're backing but don't always have a technical operator to pressure-test the strategy.
The decisions these teams face (which AI capabilities to invest in, how to turn technology into a product, what a portfolio should add up to, which vendor or hire is worth the risk) need both scientific fluency and an operator's instinct. That combination is rare on any team, and even rarer on the teams that need it most.
That's the gap we fill. We bring the operator's experience, the technical judgment, and the scientific context, and we apply them to whichever decision is in front of you this quarter.
If this sounds like your situation, or if you're not sure, write us. We read everything.
justin@pulsatance.aiFour kinds of organizations.
Building novel technology for life sciences — working at the frontier of techbio, biotech, diagnostics, devices, and therapeutics, before the path to scale is clear. Typically early-stage startups, research institutes, FROs, academic labs, and private R&D groups.
Commercializing and disseminating technology in life sciences — moving from does it work to does it scale, and growing the team and product to match. Typically scaling startups and technology companies.
Adopting and running technology in life sciences — deciding what to bring in, integrating it with existing systems, and judging whether it earns its keep. Typically large pharma, hospital systems, diagnostic networks, and CROs/CDMOs.
Investing in the future of life sciences — taking big swings and shaping what science gets done. They need scientific and technical diligence before the wire goes out, and ongoing guidance for portfolio companies after. Typically philanthropies, venture capital, angel investors, and family offices.
Four ways we work.
One to two days per week, three to twelve months. A senior operator embedded in your team, with the authority to make decisions, the scope to see them through, and the context to know when to push back.
Fixed-scope engagements, two to twelve weeks, built for rapid iteration and a defined deliverable: a program strategy, product validation, a technology assessment. Clear start, clear end, clear artifact.
Recurring and light-touch. Monthly standing time plus async input. For founders and leaders who need a thinking partner more often than they need a hire.
Half-day to multi-day engagements on AI adoption, technical strategy, or open-source practice. For teams that want to build internal capability.
Not sure which shape fits? Let's talk.
justin@pulsatance.ai